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Sample Description 
ALSPAC is a geographically limited birth cohort based on women in Avon 
(southwestern England) who were pregnant with due-dates between April and December 
1991, inclusive (Boyd et al., 2012; Fraser et al., 2013) . The initial sample size was 15247 
pregnancies, from which 14701 children survived to age 1. Over the next three decades, 
this set of parents (including mothers' partners) and children has completed an extensive 
set of questionnaires, clinical studies, and biological samples. Parental consent and child's 
assent (and child's consent, upon majority) were obtained for each measurement occasion. 
Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee 
and the Local Research Ethics Committees. Please note that the study website contains 
details of all the data that is available through a fully searchable data dictionary 
(http://www.bris.ac.uk/alspac/researchers/data-access/data-dictionary/). 
The ALSPAC children and mothers were genotyped separately. ALSPAC children 
were genotyped on Illumina HumanHap550 quad-chip platforms by the Wellcome Trust 
Sanger Institute (Cambridge, UK) and by the Laboratory Corporation of America 
(Burlington, USA). ALSPAC mothers were genotyped on Illumina HumanHap660W quad-
chip platform by Centre National de Génotypage (Évry, FR). Individuals were QC-filtered 
for: genotype missingness, X-chromosome mismatch, extreme autosomal heterozygosity, 
and cryptic relatedness (defined as IBD > 0.125). SNPs were QC-filtered for: excessive 
missingness, a significant (𝑝 < 1 × 10−6) test of Hardy-Weinberg disequilibrium, and 
minor allele frequency under 1%. 
  
The 465740 SNPs in common to mothers and children were used for phasing. 
Phasing was done with ShapeIt v2.r727 (Delaneau, Coulonges, and Zagury, 2008), based on 
a phased version of the 1000 genomes reference panel (Phase 1, Version 3), which we took 
from the Impute2 reference data repository (haplotype release date December 2013). 
Using ancestry-informative principal components, we retained 5564 duos of 
European ancestry, which was reduced to 5558 duos giving consent to all measures. Across 
the 38 phenotypes which we analyzed, the numbers of duos with complete data differed 
slightly; the smallest subsample was 2136 duos (age at menarche), while the largest was 
4753 duos (gestational age). 
We used a Perl script to resolve the parent-of-origin of children's SNPs. The script 
requires mothers' and children's phased genotypes in IMPUTE2 format (Marchini et al., 
2007). When parental origin is ambiguous (the child is heterozygous at a locus and the 
locus's membership in the two haplotypes are unclear), the alleles at the locus are assigned 
to the closest resolved haplotypes. The script outputs the phased genotypes with parent-of-
origin assigned to MACH-formatted text files. 
Phenotyping Methods 
PERINATAL MEASURES 
Length of gestation was based on last menstrual period date, ultrasound assessment 
or other clinical indicators. Where there was conflict between the maternal report and 
ultrasound assessment, an experienced obstetrician reviewed the clinical records and 
made a best estimate. Birthweight was derived from obstetric data and from central birth 
notification data: where values disagreed by <100g then the lowest value was accepted; if 
  
the values disagreed by >100g then the value was coded as missing. Crown-heel length and 
head circumference of newborns were measured by trained staff a few days after birth. 
Ponderal index was calculated as birthweight (g) x 100 / (crown heel length (cm)^3). 
ANTHROPOMETRIC MEASURES (7 year old clinic) 
Height was measured to the nearest 0.1 cm using a Harpenden stadiometer (Holtain 
Ltd., Crymych, UK) and weight was measured to the nearest 50 g using Tanita weighing 
scales (Tanita UK Ltd, Uxbridge). Sitting Height was measured using the Harpenden sitting 
height table anthropometer to the last complete mm. The child was positioned on the table 
with back straight and thighs horizontal. Feet were supported on the footrest so that the 
knees were at right angles. Waist circumference was measured to the nearest mm at the 
minimum circumference of the abdomen between the iliac crests and the lowest ribs, the 
tape was kept perpendicular to the long axis of the body, touching the skin but not 
compressing the tissue. Hip circumference was measured to the nearest mm at the point of 
maximum circumference around the child’s hips/buttocks, again with the tape kept 
perpendicular to the long axis of the body segment. The measurement was done over the 
child’s pants. Body mass index was calculated as weight (in kg) divided by height (in m) 
squared. Waist hip ratio was calculated as waist circumference (in cm) divided by hip 
circumference (in cm). 
BLOOD PRESSURE AND PULSE RATE (7 year old clinic) 
 
  
Both blood pressure and pulse rates were measured using a Dinamap 9301 Vital 
Signs monitor. Two readings of systolic and diastolic blood pressure and pulse rates were 
recorded and averages taken. 
HEMOGLOBIN (7 year old clinic) 
Blood was sampled using an EDTA tube and hemoglobin levels were measured 
using the Haemocue system. 
INTELLIGENCE (8 year old clinic) 
The WISC-III UK was used to assess cognitive function. A short form of the measure 
was employed where alternate items (always starting with item number 1 in the standard 
form) were used for all subtests, with the exception of the coding subtest which was 
administered in its full form. Hence the length of the session was reduced and children 
were less likely to tire. All tests were administered by members of the psychology team. 
The ten WISC subtests comprised five verbal subtests: 
1. Information (assessing the child’s knowledge); 
2. Similarities (where similarities between things, e.g., in what way are red and 
blue alike? must be explained); 
3. Arithmetic (comprising mental arithmetic questions); 
4. Vocabulary (ascertaining the child’s understanding of the meaning of 
different words) 
5. Comprehension (where the child is asked questions about different 
situations, e.g. why are names in the telephone book in alphabetical order?), 
 
  
and five performance subtests:  
 
1. Picture completion (where the child must point out what is missing from 
each of a series of pictures); 
2. Coding (where shapes corresponding to different numbers must be copied as 
quickly as possible within a specified time limit); 
3. Picture arrangement (where pictures must be ordered to make a meaningful 
sequence); 
4. Block design (where pictures of specific patterns of blocks are copied with 
real blocks) 
5. Object assembly (which involves putting together puzzles). 
LUNG FUNCTION MEASURES (8 year old clinic) 
American Thoracic Society (1995) criteria were used as the basis to select lung 
function measurements that were acceptable for analysis. Spirometers were calibrated at 
the beginning of each half-day session according to the manufacturer’s instructions using a 
1L calibration syringe. Pneumotachograph screens were dried with warm air between 
subjects and cleaned at the end of each day’s testing, being allowed to dry overnight. 
Measurements were made in the sitting position without nose-clips. Children were 
instructed to fill their lungs completely and blow as hard and fast as possible until there 
was ‘no air’ left in their lungs. An on-screen incentive was used to encourage maximal 
expiratory effort (this comprised a visual of a fairground bell-and-hammer’ game – the 
object being to ring the bell). ‘Start of test’ criteria were automated within the Spirotrac 
  
programme and manoeuvres failing to meet these were rejected. Each subject was 
instructed to blow at least three times to produce a maximal expiratory manoeuvre. 
Repeatability criteria were set to three manoeuvres within 200ml FVC. Most children could 
not sustain forced expiration for the recommended 6s period. Curves were accepted if they 
reached a clear plateau of flow and the expiration had continued for >1 second and was 
judged by the tester to be a maximal effort. The best of three curves was selected for 
analysis (on the basis of an acceptable curve with the highest FVC measurement). All flow-
volume curves were inspected post-hoc by a respiratory paediatrician (John Henderson) to 
ensure that satisfactory reproducibility criteria had been met and the optimal curve was 
selected for analysis. 
Standard deviation scores adjusted for height, age and gender were calculated for 
FVC (the volume change of the lung between a full inspiration to total lung capacity and a 
maximal expiration to residual volume) and FEV1 (the volume exhaled during the first 
second of a forced expiratory manoeuvre started from the level of total lung capacity). The 
ratio of FEV1:FVC was calculated on the unadjusted values. 
DXA DERIVED MEASURES (9 year old clinic) 
Total body DXA scans were performed on all participants using a Lunar Prodigy 
scanner (Lunar Radiation Corp, Madison, WI) with paediatric scanning software (GE 
Healthcare Bio-Sciences Corp., Piscataway, NJ). DXA measures of BMD and bone area were 
derived for total body (less head). All DXA scans were subsequently reviewed by a trained 
researcher, and re-analysed as necessary, to ensure that borders between adjacent ROI’s 
were placed correctly by the automated software. The coefficient of variation for Total 
Body Less Head BMD measures was 0.8%, based on the analysis of 122 children who had 
  
two scans performed on the same day. Data on lean mass and fat mass (total body) were 
also obtained from the same scans. 
BLOOD MEASURES (9 year old clinic) 
Non-fasting blood samples were taken using standard procedures, with samples 
spun immediately and frozen at -80C. The measurements were assayed in 2008 after a 
median of 7.5 years in storage with no previous freeze-thaw cycles during this period Total 
plasma adiponectin concentrations were determined using ELISA (R&D Systems, Abingdon, 
UK), with the interassay coefficient of variation (CV) being 7%. Plasma lipids (i.e., total 
cholesterol, triglycerides, and high-density lipoprotein cholesterol) measured by a 
modification of the standard Lipid Research Clinics Protocol using enzymatic reagents for 
lipid determinations, leptin measured by an in-house ELISA validated against commercial 
methods, high-sensitivity interleukin 6 (IL-6) measured by ELISA (R&D Systems, Abingdon, 
UK), and C-reactive protein (CRP) measured by automated particle-enhanced immune-
turbidimetric assay (Roche UK). All assay coefficients of variation were less than 5 % 
(Sayers et al. 2010). 
2D:4D RATIO (11 year old clinic) 
Participants’ hands were photocopied during the eleven year old clinic visit, and 
measurements of the second and fourth fingers were taken from the photocopies with the 
use of digital calipers (accurate to 0.1 mm). The 2D:4D was calculated as the length of the 
second digit divided by the length of the fourth digit. 
 
  
AGE AT MENARCHE 
Age at menarche was derived from a series of nine postal questionnaires pertaining 
to pubertal development, sent approximately yearly from age 8 to 17 years. The 
questionnaires asked ‘Has your daughter started her menstrual periods yet?’ and, if yes: 
‘How old was your daughter when she had her first period?’ Answers were given in years 
and months. These data were supplemented by questionnaires administered to girls at two 
research clinics attended at 12 years 10 months and 13 years 10 months asking ‘Have you 
started your periods yet?’ and, if yes: ‘When did you have your first period?’ The first-
reported age at onset was used, as these results are least likely to be affected by recall bias 
(Sequeira et al. 2017). 
TRANSFORMATIONS 
The following variables were highly skewed and so subjected to inverse normal 
transformations before analysis: waist hip ratio, hip circumference, waist circumference, 
BMI, ponderal index, FEV1/FVC ratio, bone area, fat mass, lean mass, triglycerides, VLDL, 
LDL, HDL, IL6, CRP, Leptin and adiponectin. 
 
  
  
Supplementary Tables 
Table SI: Diagonal elements of ALSPAC GRMs 
Summary statistics of the diagonal elements of GRMs of individuals in the ALSPAC data, for 
the additive (𝐴𝑖𝑖), dominance (𝛥𝑖𝑖), and parent-of-origin effects (𝛤𝑖𝑖), respectively. The 
expected value for each is 1 in the absence of inbreeding. 
GRM N mean sd median trimmed mad Min max range skew kurtosis 
𝐴𝑖𝑖  4753 1.0 0.01 1 1.0 0.01 0.98 1.03 0.05 0.24 0.41 
𝛥𝑖𝑖  4753 1.0 0.03 1 1.0 0.02 0.93 1.18 0.25 0.65 1.25 
𝛤𝑖𝑖  4753 0.98 0.01 0.98 0.98 0.01 0.96 1.02 0.06 0.19 0.45 
 
  
 
  
Table SII: Descriptive Statistics of 36 ALSPAC Phenotypes 
 
Phenotype Units N Mean SD Min Max 
Mean 
Age(Months) 
Age 
SD 
Min 
Age 
Mx 
Age 
2D:4D 
(Left hand) 
- 3847 0.966 0.032 0.844 1.087 140.781 2.721 127 163 
Adiponectin ng/ml 2972 13193.417 5490.027 90.368 43064.130 - - - - 
Age at first tooth months 4262 6.989 2.364 1.000 16.000 - - - - 
Age at Menarche Years 2136 12.673 1.145 8.417 16.667 - - - - 
Birth Weight G 4689 3487.250 469.701 1752.000 5140.000 - - - - 
Body Mass Index - 4065 16.187 2.001 10.848 29.686 89.997 3.133 82 113 
Bone Area cm2 3858 1136.374 161.243 679.381 1820.254 118.213 3.602 105 138 
Bone Mineral Density g/cm2 3858 0.777 0.053 0.603 0.982 118.213 3.602 105 138 
C-reactive Protein mg/L 2974 0.735 2.442 0.010 67.440 - - - - 
Crown Heel Length cm 3848 50.910 2.145 42.000 59.000 - - - - 
Diastolic Blood Pressure mmHg 4013 56.202 6.440 37.000 82.500 90.000 3.149 82 113 
Fat Mass G 3858 8489.803 4955.289 1268.194 34205.771 118.213 3.602 105 138 
FEV1 Z score 3624 0.021 0.979 -3.768 3.782 103.467 3.331 89 124 
FEV1/FVC - 3625 0.885 0.066 0.501 1.000 103.467 3.330 89 124 
FVC Z score 3675 0.009 0.975 -3.205 3.994 103.470 3.319 89 124 
Gestational Age weeks 4753 39.807 1.284 37.000 44.000 - - - - 
HDL mmol/L 2974 1.400 0.307 0.440 2.680 - - - - 
Head Circumference cm 3894 34.937 1.273 30.500 40.000 - - - - 
Height cm 4069 125.861 5.546 104.400 148.200 89.992 3.116 82 113 
Hemoglobin g/L 3217 124.549 7.588 95.000 156.000 90.040 3.237 82 113 
Hip Circumference cm 4064 65.431 5.176 51.400 95.200 89.995 3.130 82 113 
  
Interleukin-6 pg/ml 2966 1.271 1.572 0.007 20.051 - - - - 
LDL mmol/L 2974 2.353 0.595 0.563 9.184 - - - - 
Lean Mass g 3858 24498.312 3172.135 15847.163 42012.328 118.213 3.602 105 138 
Leptin ng/mL 2973 8.253 8.109 0.900 92.000 - - - - 
Number of teeth (15 
months) 
- 4376 9.591 3.326 0.000 20.000 - - - - 
Performance IQ - 3847 100.549 16.826 46.000 145.000 103.475 3.410 89 125 
Ponderal Index gx100/cm3 3795 2.632 0.242 1.566 4.025 - - - - 
Pulse Rate Bpm 4013 82.920 10.610 42.000 126.000 90.000 3.149 82 113 
Sitting Height cm 4068 67.990 2.773 59.200 78.800 89.998 3.132 82 113 
Systolic Blood Pressure mmHg 4016 98.640 9.067 66.500 135.000 89.998 3.147 82 113 
Total IQ - 3836 105.454 16.265 45.000 149.000 103.475 3.414 89 125 
Triglycerides mmol/L 2974 1.141 0.584 0.180 8.910 - - - - 
Verbal IQ - 3850 108.536 16.638 50.000 155.000 103.477 3.423 89 125 
Waist-Hip Ratio - 4062 0.861 0.041 0.685 1.030 89.992 3.123 82 113 
Waist Circumference cm 4065 56.348 5.057 46.200 90.000 89.997 3.132 82 113 
N: Number of 
SD: Standard deviation 
Min: Minimum 
Max: Maximum 
 
  
Table SIII: GCTA Estimates of G-REMLadp models in ALSPAC 
Variance component estimates of 36 standardized phenotypes in ALSPAC, estimates and standard errors generated 
using GCTA-GREML to estimate multiple components simultaneously. VarA: proportion of phenotypic variance 
attributable to additive genetic effects; SEvarA: standard error of proportion of phenotypic variance attributable to 
additive genetic effects. VarD: proportion of phenotypic variance attributable to dominance effects; SEvarD: 
standard error of proportion of phenotypic variance attributable to dominance effects. VarP: proportion of 
phenotypic variance attributable to parent-of-origin effects; SEvarP: standard error of proportion of phenotypic 
variance attributable to parent-of-origin effects. Compare Table SIV for estimates fit using GCTA-GREML to fit 
single variance components and Table SVII for estimates based on unstandardized phenotypes.  
 
Phenotype VarA SEvarA VarD SEvarD VarP SEvarP 
2D:4D (Left hand) 0.301 0.090 -0.019 0.133 -0.025 0.091 
Adiponectin 0.140 0.117 -0.123 0.169 -0.039 0.118 
Age at first tooth 0.425 0.083 0.114 0.121 0.156 0.082 
Age at Menarche 0.337 0.162 0.195 0.246 0.179 0.162 
Birth Weight 0.317 0.075 -0.118 0.110 0.021 0.074 
Body Mass Index 0.399 0.087 -0.010 0.128 0.086 0.087 
Bone Area 0.455 0.091 -0.065 0.133 0.086 0.090 
Bone Mineral Density 0.454 0.091 -0.075 0.133 0.084 0.090 
C-reactive Protein 0.165 0.115 0.119 0.172 0.068 0.119 
Crown Heel Length 0.292 0.090 -0.138 0.132 0.038 0.091 
Diastolic Blood Pressure 0.193 0.088 -0.076 0.132 0.114 0.088 
Fat Mass 0.502 0.090 0.339 0.134 0.016 0.088 
FEV1 0.300 0.098 -0.040 0.140 0.073 0.100 
FEV1/FVC 0.376 0.097 0.060 0.143 0.018 0.096 
FVC 0.370 0.097 0.017 0.136 0.159 0.097 
Gestational Age 0.175 0.074 0.132 0.112 -0.055 0.072 
HDL 0.114 0.114 -0.201 0.171 -0.024 0.117 
Head Circumference 0.433 0.089 0.042 0.134 -0.095 0.088 
Height 0.468 0.088 0.029 0.128 -0.146 0.082 
Hemoglobin 0.423 0.107 0.274 0.159 0.038 0.108 
Hip Circumference 0.507 0.088 -0.026 0.129 0.060 0.086 
Interleukin-6 0.115 0.119 0.255 0.174 0.092 0.118 
LDL 0.124 0.117 -0.184 0.173 0.072 0.118 
Lean Mass 0.356 0.091 0.133 0.138 0.009 0.091 
Leptin 0.416 0.117 0.018 0.170 0.041 0.115 
Number of teeth (15 months) 0.325 0.082 -0.011 0.117 0.019 0.079 
Performance IQ 0.209 0.090 0.230 0.135 -0.029 0.091 
Ponderal Index 0.237 0.094 0.005 0.137 -0.018 0.090 
  
Pulse Rate 0.112 0.087 -0.044 0.128 -0.051 0.084 
Sitting Height 0.450 0.087 0.085 0.127 -0.111 0.083 
Systolic Blood Pressure 0.313 0.088 -0.147 0.130 0.145 0.088 
Total IQ 0.357 0.089 0.260 0.134 -0.142 0.088 
Triglycerides 0.013 0.115 -0.063 0.171 -0.057 0.120 
Verbal IQ 0.440 0.089 0.295 0.133 -0.098 0.089 
Waist-Hip Ratio 0.100 0.085 -0.242 0.124 -0.022 0.085 
Waist Circumference 0.450 0.088 -0.091 0.127 -0.019 0.085 
  
  
Table SIV: Single-component GCTA Estimates of G-REMLadp models in 
ALSPAC 
Standardized variance component estimates of 36 phenotypes in ALSPAC generated using three runs of GCTA-
GREML, fitting single components each time. VarA: proportion of phenotypic variance attributable to additive 
genetic effects; SEvarA: standard error of proportion of phenotypic variance attributable to additive genetic effects. 
VarD: proportion of phenotypic variance attributable to dominance effects; SEvarD: standard error of proportion 
of phenotypic variance attributable to dominance effects. VarP: proportion of phenotypic variance attributable to 
parent-of-origin effects; SEvarP: standard error of proportion of phenotypic variance attributable to parent-of-
origin effects. Compare Table SIII for estimates fit using GCTA-GREML to fit multiple variance components. 
 
 
 
Phenotype VarA SEvarA VarD SEvarD VarP SEvarP 
2D:4D (Left hand) 0.302 0.090 -0.036 0.134 -0.032 0.092 
Adiponectin 0.142 0.117 -0.128 0.169 -0.040 0.118 
Age at first tooth 0.415 0.084 0.097 0.123 0.138 0.083 
Age at Menarche 0.334 0.162 0.198 0.248 0.170 0.163 
Birth Weight 0.312 0.075 -0.092 0.111 0.008 0.074 
Body Mass Index 0.396 0.088 -0.029 0.130 0.068 0.088 
Bone Area 0.449 0.092 -0.036 0.136 0.059 0.091 
Bone Mineral Density 0.448 0.092 -0.048 0.135 0.057 0.091 
C-reactive Protein 0.169 0.115 0.120 0.172 0.077 0.119 
Crown Heel Length 0.293 0.090 -0.141 0.133 0.030 0.092 
Diastolic Blood Pressure 0.191 0.088 -0.045 0.132 0.116 0.088 
Fat Mass 0.502 0.090 0.339 0.136 0.025 0.090 
FEV1 0.299 0.099 -0.040 0.141 0.070 0.100 
FEV1/FVC 0.376 0.098 0.052 0.144 0.028 0.097 
FVC 0.371 0.097 0.038 0.138 0.164 0.098 
Gestational Age 0.174 0.074 0.127 0.113 -0.056 0.072 
HDL 0.112 0.114 -0.199 0.171 -0.038 0.117 
Head Circumference 0.436 0.089 0.036 0.136 -0.109 0.088 
Height 0.474 0.088 0.036 0.129 -0.163 0.083 
Hemoglobin 0.437 0.107 0.330 0.161 0.055 0.109 
Hip Circumference 0.505 0.088 -0.024 0.131 0.041 0.087 
Interleukin-6 0.116 0.120 0.264 0.174 0.094 0.118 
LDL 0.119 0.117 -0.176 0.173 0.080 0.119 
Lean Mass 0.359 0.091 0.152 0.139 -0.019 0.091 
Leptin 0.417 0.117 0.061 0.171 0.039 0.116 
  
Number of teeth (15 months) 0.326 0.082 -0.028 0.117 0.021 0.079 
Performance IQ 0.218 0.090 0.246 0.135 -0.031 0.092 
Ponderal Index 0.238 0.094 0.029 0.138 -0.025 0.090 
Pulse Rate 0.110 0.087 -0.044 0.128 -0.051 0.084 
Sitting Height 0.453 0.087 0.066 0.128 -0.129 0.083 
Systolic Blood Pressure 0.303 0.088 -0.085 0.131 0.150 0.089 
Total IQ 0.364 0.089 0.281 0.135 -0.158 0.089 
Triglycerides 0.013 0.115 -0.066 0.171 -0.059 0.120 
Verbal IQ 0.441 0.089 0.296 0.134 -0.122 0.089 
Waist-Hip Ratio 0.097 0.086 -0.239 0.124 -0.021 0.086 
Waist Circumference 0.450 0.088 -0.080 0.130 -0.029 0.086 
  
  
Table SV: HE Regression Estimates of G-REMLadp models in ALSPAC 
Variance component estimates of 36 standardized phenotypes in ALSPAC, estimates and standard errors generated 
with single-components HE regression. VarA: proportion of phenotypic variance attributable to additive genetic 
effects; SEvarA: standard error of proportion of phenotypic variance attributable to additive genetic effects. VarD: 
proportion of phenotypic variance attributable to dominance effects; SEvarD: standard error of proportion of 
phenotypic variance attributable to dominance effects. VarP: proportion of phenotypic variance attributable to 
parent-of-origin effects; SEvarP: standard error of proportion of phenotypic variance attributable to parent-of-
origin effects. Compare Table SIII for estimates fit using GCTA-GREML to estimate variance components. 
 
Phenotype VarA SEvarA VarD SEvarD VarP SEvarP 
2D:4D (Left hand) 0.298 0.136 -0.010 0.191 -0.039 0.124 
Adiponectin 0.135 0.165 -0.089 0.251 -0.067 0.167 
Age at first tooth 0.402 0.115 0.099 0.175 0.134 0.118 
Age at Menarche 0.321 0.228 0.112 0.332 0.169 0.236 
Birth Weight 0.294 0.104 -0.104 0.152 -0.008 0.108 
Body Mass Index 0.383 0.121 -0.018 0.180 0.070 0.121 
Bone Area 0.475 0.129 -0.006 0.186 0.049 0.126 
Bone Mineral Density 0.475 0.129 -0.016 0.186 0.046 0.126 
C-reactive Protein 0.132 0.160 0.206 0.248 0.073 0.165 
Crown Heel Length 0.291 0.133 -0.106 0.187 -0.004 0.127 
Diastolic Blood Pressure 0.178 0.118 -0.012 0.183 0.117 0.125 
Fat Mass  0.483 0.089 0.384 0.135 0.013 0.091 
FEV1 0.274 0.138 -0.064 0.201 0.058 0.136 
FEV1/FVC 0.372 0.135 0.032 0.198 0.010 0.138 
FVC 0.341 0.134 0.020 0.207 0.154 0.135 
Gestational Age 0.180 0.102 0.130 0.149 -0.063 0.107 
HDL 0.118 0.171 -0.189 0.244 -0.050 0.164 
Head Circumference 0.430 0.134 -0.181 0.133 -0.097 0.128 
Height 0.448 0.121 -0.015 0.177 -0.176 0.123 
Hemoglobin 0.473 0.156 0.317 0.237 0.066 0.160 
Hip Circumference 0.425 0.120 -0.030 0.174 0.048 0.124 
Interleukin-6 0.071 0.161 0.258 0.250 0.091 0.170 
LDL 0.118 0.157 -0.139 0.246 0.025 0.163 
Lean Mass 0.388 0.128 0.135 0.189 -0.014 0.129 
Leptin 0.362 0.168 0.151 0.256 0.013 0.168 
Number of teeth (15 months) 0.301 0.110 -0.043 0.171 0.011 0.113 
Performance IQ 0.221 0.130 0.244 0.192 -0.032 0.124 
Ponderal Index 0.216 0.126 0.013 0.197 -0.027 0.135 
Pulse Rate 0.105 0.123 -0.032 0.183 -0.057 0.126 
  
Sitting Height 0.435 0.121 0.052 0.180 -0.146 0.125 
Systolic Blood Pressure 0.300 0.124 -0.051 0.179 0.147 0.121 
Total IQ 0.400 0.136 0.261 0.192 -0.162 0.128 
Triglycerides 0.022 0.167 -0.059 0.248 -0.047 0.165 
Verbal IQ 0.484 0.138 0.286 0.196 -0.128 0.129 
Waist-Hip Ratio 0.021 0.118 -0.233 0.174 -0.005 0.122 
Waist Circumference 0.425 0.120 -0.070 0.180 -0.037 0.124 
  
  
  
Table SVI: Accuracy of 𝝌𝟐 approximations across all simulations 
Accuracy of 𝜒2 approximations to noncentral 𝐹, measured as percent relative difference 
("%Diff") between the average test statistic observed in the simulations and the expected 
value. This has been computed over all simulation replicates performed for this study. N: 
Number of simulated phased genotypes; Parent Corr: average correlation of simulated 
parental genotypes; MAF Diff: average difference in simulated parental MAFs; #Reps: number 
of simulated replications; POE Wald %Diff: percent relative difference between the observed 
1-df Wald test statistic for HE regression of parent-of-origin variance components and the 
expected value, averaged across simulated replications; HE 𝐹 %Diff is 3-df 𝐹 test is the 
percent relative difference between the 3-df Wald test of additive, dominance, and parent-of-
origin variance components in Haseman-Elston regression and the expected value, averaged 
across simulated replications; REML LRT %Diff: the percent relative difference between the 3-
df 𝜒2 test of additive, dominance, and parent-of-origin variance components from REML 
fitting using GCTA and the expected value, averaged across simulated replications. 
N 
Parent 
Corr 
MAF 
Diff #Reps 
POE Wald 
%Diff 
HE 𝐹 
Diff 
REML LRT 
Diff 
1000 0.00 0.00 2727 4.629 -11.660 -10.550 
1000 0.00 0.05 900 1.371 -40.240 -41.590 
1000 0.25 0.00 876 -17.770 58.080 -32.670 
1000 0.25 0.05 504 -16.660 -23.200 -37.190 
2000 0.00 0.00 2775 -0.058 -19.010 -16.100 
2000 0.00 0.05 900 1.292 -55.990 -60.040 
2000 0.25 0.00 900 -32.830 60.010 -48.060 
2000 0.25 0.05 876 -30.460 -29.630 -48.330 
4000 0.00 0.00 2675 2.240 -21.770 -22.980 
4000 0.00 0.05 888 -2.641 -63.860 -66.920 
4000 0.25 0.00 600 -45.610 51.890 -57.480 
4000 0.25 0.05 600 -43.710 -35.000 -56.030 
5000 0.00 0.00 280 2.702 1.745 1.752 
5000 0.00 0.05 280 -2.181 -1.452 -5.536 
7500 0.00 0.00 250 -10.930 -4.248 0.628 
7500 0.00 0.05 240 6.520 6.118 12.700 
 
  
 
Table SVII: GCTA Estimates of G-REMLadp models of unstandardized phenotypes in ALSPAC  
Variance component estimates of 36 unstandardized phenotypes in ALSPAC, estimates and standard errors generated using GCTA-GREML to estimate multiple 
components simultaneously. VarA: proportion of phenotypic variance attributable to additive genetic effects; SEvarA: standard error of proportion of phenotypic 
variance attributable to additive genetic effects. VarD: proportion of phenotypic variance attributable to dominance effects; SEvarD: standard error of 
proportion of phenotypic variance attributable to dominance effects. VarP: proportion of phenotypic variance attributable to parent-of-origin effects; SEvarP: 
standard error of proportion of phenotypic variance attributable to parent-of-origin effects. VarE: estimate of phenotypic error variance; SEvarE: standard 
error of estimate of phenotypic error variance. PhVar: Estimate of phenotypic variance. PhSE: Standard error of phenotypic variance estimate. Compare Table 
SIV for estimates based on standardized phenotypes. See Table SIII for descriptive statistics for each phenotype.  
 
Phenotype VarA SEvarA VarD SEvarD VarP SEvarP VarE SEvarE PhVar PhSE 
2D:4D 
(Left hand) 
3.0x10-4 9.2x10-5 -2.0x10-5 1.4x10-5 -2.5x10-5 9.2x10-5 7.5x10-4 1.9x10-4 1.0x10-3 2.3x10-5 
Adiponectin 0.136 0.114 -0.120 0.166 -0.038 0.115 0.998 0.234 0.976 0.025 
Age at first 
tooth 
2.376 0.474 0.636 0.678 0.873 0.459 1.700 0.938 5.585 0.122 
Age at 
Menarche 
0.443 0.214 0.257 0.324 0.236 0.214 0.380 0.440 1.316 0.041 
Birth Weight 68668.472 16478.140 -
25620.92 
23774.703 4548.509 15960.585 169126.413 32808.301 216722.430 4506.383 
Body Mass 
Index 
0.382 0.085 -0.009 0.123 0.082 0.083 0.504 0.172 0.959 0.021 
Bone Area 0.430 0.088 -0.062 0.126 0.082 0.085 0.495 0.175 0.945 0.022 
Bone Mineral 
Density 
1.3x10-3 2.6x10-4 -2.1x10-4 3.7x10-4 2.4x10-4 2.5x10-4 1.5x10-3 5.2x10-4 2.8x10-3 6.5x10-5 
C-reactive 
Protein 
0.153 0.107 0.111 0.160 0.064 0.111 0.603 0.219 0.931 0.024 
Crown Heel 
Length 
1.298 0.404 -0.612 0.586 0.168 0.407 3.588 0.819 4.443 0.102 
  
Diastolic BP 7.978 3.654 -3.131 5.461 4.704 3.649 31.842 7.346 41.394 0.930 
Fat Mass 0.441 0.081 0.297 0.118 0.014 0.077 0.126 0.159 0.878 0.020 
FEV1 0.288 0.095 -0.039 0.135 0.070 0.096 0.642 0.190 0.961 0.023 
FEV1/FVC 0.371 0.098 0.059 0.141 0.018 0.095 0.540 0.195 0.988 0.023 
FVC 0.353 0.094 0.016 0.130 0.152 0.093 0.434 0.180 0.954 0.022 
Gest. Age 0.289 0.122 0.217 0.185 -0.090 0.118 1.229 0.251 1.644 0.034 
HDL 0.110 0.110 -0.194 0.166 -0.024 0.113 1.073 0.226 0.965 0.025 
Head 
Circumference 
0.650 0.136 0.063 0.201 -0.143 0.131 0.931 0.275 1.501 0.034 
Height 14.298 2.736 0.899 3.895 -4.448 2.507 19.772 5.357 30.520 0.682 
Hemoglobin 24.284 6.254 15.722 9.131 2.203 6.181 15.242 12.208 57.451 1.444 
Hip 
Circumference 
0.472 0.084 -0.024 0.120 0.056 0.080 0.427 0.166 0.931 0.021 
Interleukin-6 0.115 0.119 0.253 0.173 0.091 0.117 0.533 0.237 0.992 0.026 
LDL 0.119 0.113 -0.177 0.166 0.069 0.114 0.949 0.228 0.960 0.025 
Lean Mass 0.310 0.080 0.116 0.121 0.008 0.079 0.437 0.165 0.870 0.020 
Leptin 0.359 0.102 0.015 0.147 0.035 0.099 0.453 0.200 0.862 0.023 
Number of 
teeth (15 
months) 
3.597 0.919 -0.120 1.292 0.211 0.869 7.368 1.808 11.056 0.238 
Perform. IQ 59.208 25.498 64.957 38.142 -8.068 25.794 166.771 51.841 282.867 6.474 
Ponderal Index 1.4x10-2 5.5x10-3 3.0x10-4 8.0x10-3 -1.1x10-3 5.2x10-3 4.5x10-2 1.1x10-2 0.059 1.4x10-3 
Pulse Rate 12.366 9.662 -4.904 14.185 -5.660 9.340 108.920 19.315 110.723 2.477 
Sitting Height 3.408 0.675 0.641 0.960 -0.844 0.627 4.373 1.331 7.578 0.169 
Systolic BP 25.804 7.294 -12.141 10.707 11.940 7.307 56.874 14.479 82.477 1.858 
Total IQ 94.213 23.878 68.501 35.524 -37.494 23.310 138.613 48.441 263.833 6.056 
Triglycerides 0.013 0.114 -0.062 0.169 -0.056 0.119 1.098 0.236 0.993 0.026 
Verbal IQ 121.119 25.017 81.285 36.742 -26.993 24.417 100.077 50.481 275.488 6.328 
  
Waist-Hip Ratio 1.5x10-4 1.3x10-4 -3.5x10-4 1.8x10-4 -3.2x10-5 1.2x10-4 1.7x10-3 2.6x10-4 1.5x10-3 3.2x10-5 
Waist 
Circumference 
0.423 0.084 -0.086 0.120 -0.018 0.080 0.620 0.166 0.939 0.021 
  
  
Supplementary Figures 
S1: Scatterplot matrix of off diagonal elements of ALSPAC GRMs 
  
Scatterplot matrix of off diagonal elements of genetic relationship matrices for additive, dominance, and parent-of-origin effects, 
taken from the analysis of gestational age in ALSPAC. See Tables SII, SIII, and SVII for descriptive statistics and G-REMLadp model 
results from this analysis. 
  
 
S2: Expected power to detect parent-of-origin effects tagged by 𝒎 = 𝟏𝟎𝟎𝟎𝟎 loci  
Expected power to detect parent-of-origin effects tagged by 𝑚 = 10000 loci, by sample size: Curves generated using Haseman-
Elston regression approximation to the Wald test of nonzero effect. %PoE: proportion of phenotypic variance attributable to parent-of-
origin effects; Sample size: number of unrelated individuals with phased genotypes in the sample that would be used to estimate 
POEs; Power: proportion of test statistics generated under a non-null distribution with noncentrality parameter as given in Equation 4 
that would exceed a 95% critical value in the Wald test of a null variance component. 
  
  
 
 
  
  
  
  
S3: Wald test statistics for simulated additive effects 
Observed Wald test statistics for simulated additive effects, averaged over replications, versus their expected values. Averaged 
observed 𝜒2 is the mean Wald test statistic over replications, within a particular simulated condition; Expected 𝜒2 is the 
expected Wald test statistic for that effect size; Correlation between parental genotypes: the average correlation between 
maternal and paternal transmitted genotypes, circles being no correlation, triangles low correlation, 𝑟 = 0.025, and squares 
high correlation, 𝑟 = 0.25; Sample size, coded by point colour is the number of simulated children with phased, parent-of-
origin determined genotypes; Variance component size, coded by point size, is the population value of the proportion of 
phenotypic variance explained by the simulated additive effects. The black line is the line of equality. 
  
  
 
  
  
  
  
S4: Wald test statistics for simulated dominance effects 
Observed Wald test statistics for simulated dominance effects, averaged over replications, versus their expected values. Averaged 
observed 𝜒2 is the mean Wald test statistic over replications, within a particular simulated condition; Expected 𝜒2 is the 
expected Wald test statistic for that effect size; Correlation between parental genotypes: the average correlation between 
maternal and paternal transmitted genotypes, circles being no correlation, triangles low correlation, 𝑟 = 0.025, and squares 
high correlation, 𝑟 = 0.25; Sample size, coded by point colour is the number of simulated children with phased, parent-of-
origin determined genotypes; Variance component size, coded by point size, is the population value of the proportion of 
phenotypic variance explained by the simulated additive effects. The black line is the line of equality. 
  
  
 
  
  
S5: Wald test statistics for simulated parent-of-origin effects 
Observed Wald test statistics for simulated parent-of-origin effects (POE), averaged over replications, versus their expected values. 
Averaged observed 𝜒2 is the mean Wald test statistic over replications, within a particular simulated condition; Expected 𝜒2 is 
the expected Wald test statistic for that effect size; Correlation between parental genotypes: the average correlation between 
maternal and paternal transmitted genotypes, circles being no correlation, triangles low correlation, 𝑟 = 0.025, and squares 
high correlation, 𝑟 = 0.25; Sample size, coded by point colour is the number of simulated children with phased, parent-of-
origin determined genotypes; Variance component size, coded by point size, is the population value of the proportion of 
phenotypic variance explained by the simulated additive effects. The black line is the line of equality. 
  
  
 
  
  
Appendix: Correlations between codings of phased genotypes at two loci 
Notation and Parental gametes, considering two linked loci 
Consider loci I and II, which are in linkage disequilibrium. Represent the four transmitted alleles at these loci by four random 
variables: for the first locus, 𝜏𝐼,𝑀𝑜 ,  𝜏𝐼,𝐹𝑎 and 𝜏𝐼𝐼,𝑀𝑜 ,  𝜏𝐼𝐼,𝐹𝑎 at the second locus, where 
𝜏 = {
1 if minor allele transmitted
0 if major allele transmitted
 
We assume: random mating so that 𝜏.,𝑀𝑜 are independent of 𝜏.,𝐹𝑎, and equal allele frequencies across sexes. For simplicity, 
assume that the minor allele frequencies(MAFs) are equal across loci; the results here can be extended straightforwardly to 
loci with differing MAFs. 
With MAF equal to 𝑝 and defining 𝑞 = 1 − 𝑝: 
• 𝐸(𝜏𝐼,𝑀𝑜) = 𝐸(𝜏𝐼,𝐹𝑎) = 𝐸(𝜏𝐼𝐼,𝑀𝑜) = 𝐸(𝜏𝐼𝐼,𝐹𝑎) = 𝑝 
• Because the 𝜏 are indicator variables, 𝐸(𝜏𝐼,𝑀𝑜
2 ) = 𝐸(𝜏𝐼,𝐹𝑎
2 ) = 𝐸(𝜏𝐼𝐼,𝑀𝑜
2 ) = 𝐸(𝜏𝐼𝐼,𝐹𝑎
2 ) = 𝑝 
• Var(𝜏𝐼,𝑀𝑜) = Var(𝜏𝐼,𝐹𝑎) = Var(𝜏𝐼𝐼,𝑀𝑜) = Var(𝜏𝐼𝐼,𝐹𝑎) = 𝑝 − 𝑝
2 = 𝑝𝑞 
Then, following standard notation, let 𝐷 be the covariance between gametes at the two loci. (e.g. Sved, 1968)  
The means of cross-products are: 
• 𝐸(𝜏𝐼,𝑀𝑜𝜏𝐼𝐼,𝑀𝑜) = 𝐸(𝜏𝐼,𝐹𝑎𝜏𝐼𝐼,𝐹𝑎) = 𝐷 + 𝑝
2 
By the independence of maternal and paternal gametes: 
• 𝐸(𝜏𝐼,𝑀𝑜𝜏𝐼𝐼,𝐹𝑎) = 𝐸(𝜏𝐼,𝐹𝑎𝜏𝐼𝐼,𝑀𝑜) = 𝐸(𝜏)
2 = 𝑝2 
 
• 𝐸(𝜏𝐼,𝑀𝑜𝜏𝐼,𝐹𝑎𝜏𝐼𝐼,𝑀𝑜𝜏𝐼𝐼,𝐹𝑎) = 𝐸(𝜏𝐼,𝑀𝑜𝜏𝐼𝐼,𝑀𝑜)𝐸(𝜏𝐼,𝐹𝑎𝜏𝐼𝐼,𝐹𝑎) = (𝐷 + 𝑝
2)2 
 
• 𝐸(𝜏𝐼,𝑀𝑜𝜏𝐼,𝐹𝑎𝜏𝐼𝐼,𝑀𝑜) = 𝐸(𝜏𝐼,𝐹𝑎)𝐸(𝜏𝐼,𝑀𝑜𝜏𝐼𝐼,𝑀𝑜) = 𝑝(𝐷 + 𝑝
2) 
  
Correlation between additive codings 
• Let the additive coding at locus I be 𝑋𝐴𝐼 = 𝜏𝐼,𝑀𝑜 + 𝜏𝐼,𝐹𝑎 and define 𝑋𝐴𝐼𝐼 analogously for locus II 
• Then 𝐸(𝑋𝐴𝐼) = 𝐸(𝑋𝐴𝐼𝐼) = 2𝑝 and Var(𝑋𝐴𝐼) = Var(𝑋𝐴𝐼𝐼) = 2𝑝𝑞 
• The covariance between loci is 
𝐸(𝑋𝐴𝐼𝑋𝐴𝐼𝐼) − 𝐸(𝑋𝐴𝐼)𝐸(𝑋𝐴𝐼𝐼) = 𝐸(𝜏𝐼,𝑀𝑜𝜏𝐼𝐼,𝑀𝑜 + 𝜏𝐼,𝑀𝑜𝜏𝐼𝐼,𝐹𝑎 + 𝜏𝐼,𝐹𝑎𝜏𝐼𝐼,𝑀𝑜 + 𝜏𝐼,𝐹𝑎𝜏𝐼𝐼,𝐹𝑎) − 4𝑝
2
= (𝐷 + 𝑝2) + 𝑝2 + 𝑝2 + (𝐷 + 𝑝2) − 4𝑝2
= 2𝐷
 
• This means that the correlation is 𝑟 =
2𝐷
2𝑝𝑞
=
𝐷
𝑝𝑞
, which is the typical correlation coefficient used to summarize LD 
Correlation between parent-of-origin codings 
• Let the parent-of-origin coding at locus I be 𝑋𝛾𝐼 = 𝜏𝐼,𝑀𝑜 − 𝜏𝐼,𝐹𝑎 and define 𝑋𝛾𝐼𝐼 analogously for locus II. 
• Then 𝐸(𝑋𝛾𝐼) = 𝑝 − 𝑝 = 0 = 𝐸(𝑋𝛾𝐼𝐼) 
• Var(𝑋𝛾𝐼) = 𝐸(𝜏𝐼,𝑀𝑜
2 − 2𝜏𝐼,𝑀𝑜𝜏𝐼,𝐹𝑎 + 𝜏𝐼,𝐹𝑎
2 ) = 𝑝 − 2𝑝2 + 𝑝 = 2𝑝𝑞 = Var(𝑋𝛾𝐼𝐼), which is also the same variance as in the 
additive coding. 
• The covariance is: 
𝐸(𝑋𝛾𝐼𝑋𝛾𝐼𝐼) − 𝐸(𝑋𝛾𝐼)𝐸(𝑋𝛾𝐼𝐼) = 𝐸(𝜏𝐼,𝑀𝑜𝜏𝐼𝐼,𝑀𝑜 − 𝜏𝐼,𝑀𝑜𝜏𝐼𝐼,𝐹𝑎 − 𝜏𝐼,𝐹𝑎𝜏𝐼𝐼,𝑀𝑜 + 𝜏𝐼,𝐹𝑎𝜏𝐼𝐼,𝐹𝑎) − 0
= (𝐷 + 𝑝2) − 𝑝2 − 𝑝2 + (𝐷 + 𝑝2)
= 2𝐷
 
• This means that the correlation is also 𝑟 =
2𝐷
2𝑝𝑞
=
𝐷
𝑝𝑞
 
Correlation between dominance codings 
• Let the dominance coding at locus I be 𝑋𝛥𝐼 = 2𝑝𝑋𝐴𝐼 − 2𝜏𝐼,𝑀𝑜𝜏𝐼,𝐹𝑎 = 2𝑝𝜏𝐼,𝑀𝑜 + 2𝑝𝜏𝐼,𝐹𝑎 − 2𝜏𝐼,𝑀𝑜𝜏𝐼,𝐹𝑎 and define 𝑋𝛥𝐼𝐼 
analogously for locus II. 
• Then 𝐸(𝑋𝛥𝐼) = 2𝑝
2 + 2𝑝2 − 2𝑝2 = 2𝑝2 = 𝐸(𝑋𝛥𝐼𝐼) 
• The variance is: 
  
Var(𝑋𝛥𝐼) = 𝐸𝑋𝛥𝐼
2 − 𝐸𝑋𝛥𝐼
2
= 𝐸(4𝑝2𝜏𝐼,𝑀𝑜
2 + 4𝑝2𝜏𝐼,𝐹𝑎
2 + 8𝑝2𝜏𝐼,𝑀𝑜𝜏𝐼,𝐹𝑎 − 8𝑝𝜏𝐼,𝑀𝑜
2 𝜏𝐼,𝐹𝑎 − 8𝑝𝜏𝐼,𝑀𝑜𝜏𝐼,𝐹𝑎
2 + 4𝜏𝐼,𝑀𝑜
2 𝜏𝐼,𝐹𝑎
2 ) − 4𝑝4
= 4𝑝3 + 4𝑝3 + 8𝑝4 − 8𝑝3 − 8𝑝3 + 4𝑝2 − 4𝑝4
= 4𝑝4 − 8𝑝3 + 4𝑝2
= 4𝑝2(𝑝2 − 2𝑝 + 1)
= 4𝑝2𝑞2
= Var(𝑋𝛥𝐼𝐼)
 
– , which is the square of the variance of the additive coding 
• The covariance is: 
Cov(𝑋𝛥𝐼 ,  𝑋𝛥𝐼𝐼) = 𝐸(𝑋𝛥𝐼𝑋𝛥𝐼𝐼) − 𝐸(𝑋𝛥𝐼)𝐸(𝑋𝛥𝐼𝐼)
= 𝐸 ((2𝑝𝜏𝐼,𝑀𝑜 + 2𝑝𝜏𝐼,𝐹𝑎 − 2𝜏𝐼,𝑀𝑜𝜏𝐼,𝐹𝑎)(2𝑝𝜏𝐼𝐼,𝑀𝑜 + 2𝑝𝜏𝐼𝐼,𝐹𝑎 − 2𝜏𝐼𝐼,𝑀𝑜𝜏𝐼𝐼,𝐹𝑎)) − 4𝑝
4
= 𝐸(4𝑝2𝜏𝐼,𝑀𝑜𝜏𝐼𝐼,𝑀𝑜 + 4𝑝
2𝜏𝐼,𝑀𝑜𝜏𝐼𝐼,𝐹𝑎 − 4𝑝𝜏𝐼,𝑀𝑜𝜏𝐼𝐼,𝑀𝑜𝜏𝐼𝐼,𝐹𝑎)
 +𝐸(4𝑝2𝜏𝐼,𝐹𝑎𝜏𝐼𝐼,𝐹𝑎 + 4𝑝
2𝜏𝐼,𝐹𝑎𝜏𝐼𝐼,𝑀𝑜 − 4𝑝𝜏𝐼,𝐹𝑎𝜏𝐼𝐼,𝐹𝑎𝜏𝐼𝐼,𝑀𝑜)
 +𝐸(−4𝑝𝜏𝐼,𝐹𝑎𝜏𝐼,𝑀𝑜𝜏𝐼𝐼,𝑀𝑜 − 4𝑝𝜏𝐼,𝐹𝑎𝜏𝐼,𝑀𝑜𝜏𝐼𝐼,𝐹𝑎 + 4𝜏𝐼,𝑀𝑜𝜏𝐼𝐼,𝑀𝑜𝜏𝐼,𝐹𝑎𝜏𝐼𝐼,𝐹𝑎) − 4𝑝
4
= 4𝑝2(𝐷 + 𝑝2) + 4𝑝4 − 4𝑝2(𝐷 + 𝑝2)
 +4𝑝2(𝐷 + 𝑝2) + 4𝑝4 − 4𝑝2(𝐷 + 𝑝2)
 −4𝑝2(𝐷 + 𝑝2) − 4𝑝2(𝐷 + 𝑝2) + 4(𝐷 + 𝑝2)2 − 4𝑝4
= 4𝑝4 − 8𝑝2(𝐷 + 𝑝2) + 4(𝐷 + 𝑝2)2
= 4(𝑝2 − (𝐷 + 𝑝2))
2
= 4𝐷2
 
- This means that the correlation is 𝑟𝛥 =
4𝐷2
4𝑝2𝑞2
=
𝐷2
𝑝2𝑞2
, which is the square of the LD correlation between locus I and locus II 
Cross-locus, cross-coding correlation: additive and parent-of-origin 
• This is relatively simple because the two codings have the same variance and the parent-of-origin coding has a mean of 0 
  
Cov(𝑋𝐴𝐼 ,  𝑋𝛾𝐼𝐼) = 𝐸 ((𝜏𝐼,𝑀𝑜 + 𝜏𝐼,𝐹𝑎)(𝜏𝐼𝐼,𝑀𝑜 − 𝜏𝐼𝐼,𝐹𝑎))
= 𝐸(𝜏𝐼,𝑀𝑜𝜏𝐼𝐼,𝑀𝑜 − 𝜏𝐼,𝑀𝑜𝜏𝐼𝐼,𝐹𝑎 + 𝜏𝐼,𝐹𝑎𝜏𝐼𝐼,𝑀𝑜 − 𝜏𝐼,𝐹𝑎𝜏𝐼𝐼,𝐹𝑎)
= (𝐷 + 𝑝2) − 𝑝2 + 𝑝2 − (𝐷 + 𝑝2)
= 0
 
• Because the covariance is 0, the correlation is as well 
Cross-locus, cross-coding correlation: additive and dominance 
Cov(𝑋𝐴𝐼 ,  𝑋𝛥𝐼𝐼) = 𝐸 ((𝜏𝐼,𝑀𝑜 + 𝜏𝐼,𝐹𝑎)(2𝑝𝜏𝐼𝐼,𝑀𝑜 + 2𝑝𝜏𝐼𝐼,𝐹𝑎 − 2𝜏𝐼𝐼,𝑀𝑜𝜏𝐼𝐼,𝐹𝑎)) − 4𝑝
3
= 𝐸(2𝑝𝜏𝐼,𝑀𝑜𝜏𝐼𝐼,𝑀𝑜 + 2𝑝𝜏𝐼,𝑀𝑜𝜏𝐼𝐼,𝐹𝑎 − 2𝜏𝐼,𝑀𝑜𝜏𝐼𝐼,𝑀𝑜𝜏𝐼𝐼,𝐹𝑎 + 2𝑝𝜏𝐼,𝐹𝑎𝜏𝐼𝐼,𝑀𝑜 + 2𝑝𝜏𝐼,𝐹𝑎𝜏𝐼𝐼,𝐹𝑎 − 2𝜏𝐼,𝐹𝑎𝜏𝐼𝐼,𝑀𝑜𝜏𝐼𝐼,𝐹𝑎) − 4𝑝
3
= 2𝑝(𝐷 + 𝑝2) + 2𝑝3 − 2𝑝(𝐷 + 𝑝2) + 2𝑝3 + 2𝑝(𝐷 + 𝑝2) − 2𝑝(𝐷 + 𝑝2) − 4𝑝3
= 0
 
Cross-locus, cross-coding correlation: parent-of-origin and dominance 
Cov(𝑋𝛾𝐼 ,  𝑋𝛥𝐼𝐼) = 𝐸 ((𝜏𝐼,𝑀𝑜 − 𝜏𝐼,𝐹𝑎)(2𝑝𝜏𝐼𝐼,𝑀𝑜 + 2𝑝𝜏𝐼𝐼,𝐹𝑎 − 2𝜏𝐼𝐼,𝑀𝑜𝜏𝐼𝐼,𝐹𝑎))
= 𝐸(2𝑝𝜏𝐼,𝑀𝑜𝜏𝐼𝐼,𝑀𝑜 + 2𝑝𝜏𝐼,𝑀𝑜𝜏𝐼𝐼,𝐹𝑎 − 2𝜏𝐼,𝑀𝑜𝜏𝐼𝐼,𝑀𝑜𝜏𝐼𝐼,𝐹𝑎 − 2𝑝𝜏𝐼,𝐹𝑎𝜏𝐼𝐼,𝑀𝑜 − 2𝑝𝜏𝐼,𝐹𝑎𝜏𝐼𝐼,𝐹𝑎 + 2𝜏𝐼,𝐹𝑎𝜏𝐼𝐼,𝑀𝑜𝜏𝐼𝐼,𝐹𝑎)
= 2𝑝(𝐷 + 𝑝2) + 2𝑝3 − 2𝑝(𝐷 + 𝑝2) − 2𝑝3 − 2𝑝(𝐷 + 𝑝2) + 2𝑝(𝐷 + 𝑝2)
= 0
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